期刊文献+

不同靶浓度瑞芬太尼对腹腔镜胆囊切除术老年患者气管拔管反应的影响 被引量:5

原文传递
导出
摘要 全麻气管拔管期间,由于导管对气道的强烈刺激可诱发应激反应,出现呛咳、血压升高和心率增快等,易导致心脑血管意外,尤其是老年患者,心脑血管意外的发生率更高.为预防气管拔管反应,常在深麻醉或静脉给予血管活性药物等条件下拔除气管导管,但可导致呼吸抑制和延长气管拔管时间等.瑞芬太尼是一种超短效的阿片类制剂,作用时间短,消除快,可减轻术后气管拔管诱发的应激反应[1].而瑞芬太尼抑制老年患者气管拔管反应的适宜浓度有待明确.本研究拟评价不同靶浓度瑞芬太尼对腹腔镜胆囊切除术老年患者气管拔管反应的影响,为临床应用提供参考.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2013年第12期1489-1490,共2页 Chinese Journal of Anesthesiology
  • 相关文献

参考文献7

二级参考文献24

  • 1安立新,王保国.瑞芬太尼用于无痛人工流产时发生肌肉僵直一例报告[J].麻醉与监护论坛,2004,11(5):371-371. 被引量:1
  • 2黄河,吴悦维,杨天德,陶军,李洪,谭虎,陈祥瑞.异丙酚靶控输注复合瑞芬太尼在纤维支气管镜检查中的应用[J].四川医学,2005,26(8):843-844. 被引量:4
  • 3张熙哲,吴新民.腰麻病人瑞芬太尼和舒芬太尼呼吸抑制的半数血浆靶浓度[J].中华麻醉学杂志,2007,27(1):58-61. 被引量:49
  • 4Barash PG,Cullen BF,Stoelting RK,著.艾登斌,马海燕,译.临床麻醉手册.第4版.北京:人民卫生出版社,2003:229.
  • 5Minto CF, Schnlder TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I . Model development. Anesthesiology, 1997,86:10-23.
  • 6Nieuwenhuijs DJ, Olofsen E, Romberg RR, et al. Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index. Anesthesiology, 2003, 98 : 312-322.
  • 7Barash PG,ed.临床麻醉学.王伟鹏,李立环,主译.第4版.北京:人民卫生出版社,2004.303.
  • 8Kashiwagi M, Okada Y, Kuwana S, et al. A neuronal mechanism of propofol-induced central respiratory depression in newborn rats. Anesth Analg, 2004, 99:49-55.
  • 9Nieuwenhuijs D, Sarton E, Teppema LJ, et al. Respiratory sites of action of propofol: absence of depression of peripheral chemoreflex loop by low-dose propofol. Anesthesiology, 2001, 95:889-895.
  • 10Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynarmics of remifentanil. Anesth Analg, 1999,89(4 Suppl) :s7-s14.

共引文献61

同被引文献39

  • 1邵新峰,邢玉英.右美托咪定在临床麻醉中应用的研究现状[J].中华临床医师杂志(电子版),2012,6(18):136-138. 被引量:24
  • 2徐爽,程守全,梁袁,黄琳.盐酸右美托咪定对高龄老年围拔管期应激反应的保护作用[J].中国老年学杂志,2014,34(4):1112-1113. 被引量:4
  • 3Furuya A,Suzuki S,Kondo S,et al.The use of dexmedetomidine and Airway scope in airway management of a child with Cornelia de Lange syndrome[J].Masui,2014,63(7):810-813.
  • 4Whalen LD,Di Gennaro JL,Irby GA,et al.Long-term dexmedetomidine use and safety profile among critically ill children and neonates[J].Pediatr Crit Care Med,2014,15(8):706-714.
  • 5Kim HS,Kim JW,Jang KT,et al.Initial experience with dexmedetomidine for dental sedation in children[J].J Clin Pediatr Dent,2013,38(1):79-81.
  • 6Dahmani S,Delivet H,Hilly J.Emergence delirium in children:an update[J].Curr Opin Anaesthesiol,2014,27(3):309-315.
  • 7Nho JS,Lee SY,Kanq JM,et al.Effect of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation[J].Br J Anaesth,2009,103(6):817-821.
  • 8Marsh DF,Hodkinson B.Remifentanil in paediatric anaesthetic practice[J].Anaesthesia,2009,64(3):301-308.
  • 9Kulikov AS,Lubnin AY.Dexmedetomidine:new opportunities in anesthesiology[J].Anesteziol Reanimatol,2013(1):37-41.
  • 10Ayeko M,Mohamed AA.Prevention and treatment of sevoflurane emergence agitation and delirium in children with dexmedetomidine[J].Saudi J Anaesth,2014,8(4):570-571.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部